Ticker ADRO – Aduro Biotech Inc – sales, description, marketcap – Tickerday.com

ADRO

Aduro Biotech Inc

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 193.99M; Volume: 80.78K; AvgVol 3m: 475.23K; Beta: 0.39;

Cost estimate:

P/E: ; EPS: -0.80; EPS growth quarter/prev quarter: 11.50%;

EPS growth this year: 15.00%; EPS growth past 5 years: -30.40%;

EPS ttm: -0.80;

P/S: 8.64; P/B: 05.07; P/Cashflow: 1.41; P/FCF: ;

Sales: 27.95M; Sales growth quarter/prev quarter: 14.30%; Sales growth past 5 years: 5.20%;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -22.30%; ROE – return on equity: -101.70%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: ; Dividend Yield (%): ;

Insider Ownership: 0.70%; Insider Transactions:-36.51%;

Institutional Ownership: 51.40%; Institutional Transactions: 32.97%;

Data update: 07.10.2020.

Leave a comment

Your email address will not be published. Required fields are marked *